Does GLP-1 Help with Cholesterol
Female-focused study contexts Research examining peptides for female fat loss generally accounts for a different hormonal baseline, since estrogen levels are understood in the literature to influence fat distribution patterns differently than in male physiology particularly around subcutaneous versus visceral fat storage
DOI: 10.1530/EC-18-0514 Camacho EM, Huhtaniemi IT, ONeill TW, et al
The effectiveness of tirzepatide for treating obesity is being evaluated in the SURMOUNT series of phase 3 RCTs, which, for the first time, demonstrated average weight reductions exceeding 20% with pharmacotherapy [23]
However, subsequent clinical trials reported high rates of nausea and vomiting, leading to the perception that PYY-based therapies were intrinsically intolerable